Mitotic event utilizes a number of kinesin-related proteins (KRPs).
INTRODUCTION
Eukaryotic cells have a set of nucleotide-dependent molecular motors to fulfill specific demands on their viability. Cell division is the most essential and evolved system that engages a number of dynein and kinesinrelated proteins (KRPs 1 ) to move mitotic spindles and chromosomes in a precise and regulated order. Most of KRPs identified so far have been shown to be involved in mitotic process (reviewed in Refs. 1-3). Kinesins generate force against microtubule, a major constituent of mitotic spindle, via the conserved motor domain capable of microtubule binding and ATP catalyzing. They are categorized into subgroups according to the similarity within this motor domain, whose roles are related as well in many cases.
The most popular type of KRP, including conventional kinesin heavy chain has its motor domain at N-terminus and the exclusive sequences are divergent in their length and similarity. The non-motor sequence is considered to determine the cargo-specificity of the molecular motor, and undergoes modification such as phosphorylation on it or protein-protein interaction that regulates the mechanochemical activity of the motor.
The transition from G2 to M phase is triggered by nuclear import of cdc2 kinase, which then phosphorylates mitotic proteins on the Ser/Thr-Pro motif to induce the consecutive events on onset of mitosis. Although the precise mechanism how this onset happens is under investigation, one description for the mechanism is proposed as the specific interaction of regulatory proteins in the state of mitotic phosphorylation. The mitotic peptidyl-prolyl isomerase (PPIase) Pin1 (4) is such a candidate that interacts with a large number of mitotic phosphoproteins including cdc25, Wee1, Myt1, Plk1, and cdc27 (5-7). Pin1 preferentially binds to phosphorylated Ser/Thr-Pro motif through the N-terminal WW domain and catalyzes the peptidyl-prolyl isomerization of proteins through the C- 4 terminal isomerase domain (8) . Mitotic phosphorylation by several kinases including cdc2 kinase causes Ser/Thr-Pro motif to interact with Pin1, although not all of mitotic phosphorylation sites are responsible for Pin1
binding. Anti-mitotic proteins MPM-2 monoclonal antibody (9) recognizes phosphoepitope that almost overlaps with a subset of mitotic phosphorylation sites accessible to Pin1. The reactive sequence for Pin1
and MPM-2 is evolutionarily conserved from yeast to higher vertebrate, and is functionally important in progression of mitosis since both the overproduction or removal of Pin1 (10) and the microinjection of MPM-2 (11) lead cells to mitotic arrest.
Here we report the identification of a novel KRP, termed KRMP1
that undergoes in vivo phosphorylation. KRMP1 has N-terminal kinesin motor domain that is most similar to emerging MKLP-1 subfamily (12) (13) (14) (15) .
KRMP1 has extraordinarily long coiled-coil domain compared to other
KRPs including known members of MKLP-1 subfamily. The C-terminal globular tail domain is strongly phosphorylated by mitotic kinase activities almost attributed to cdc2 kinase that is responsible for the phosphorylation on the residue Thr-1604 of KRMP1. Furthermore, both Pin1 and MPM-2 were reactive with mitotically phosphorylated tail domain. The interaction between KRMP1 and Pin1 is mediated through the WW domain of Pin1, and confirmed by co-immunoprecipitation analysis and also by functional study, in which the cell cycle-arrest induced by KRMP1 overexpression was overridden by the co-expression of Pin1. These data suggest that KRMP1 may be a novel Pin1 target required for mitotic regulation, or with its motor activity regulate both localization and interaction of Pin1 with other substrates to contribute to mitotic process.
EXPERIMENTAL PROCEDURES
Materials-Unless otherwise noted, routine chemical materials were obtained from either Sigma (St. Louis, MO) or Wako (Osaka, Japan). Molecular standards and restriction enzymes were purchased from New England BioLabs (Beverly, MA).
Recombinant cdc2 kinase was purchased from Promega (Madison, WI). Olomoucine was purchased from Calbiochem (La Jolla, CA).
Antibodies-The monoclonal antibodies (mAb) to the hemagglutinin (HA) epitope tag (12CA5, Roche Diagnostics, Mannheim, Germany), the FLAG epitope tag (M2, Sigma) were purchased from the indicated suppliers. Anti-α-tubulin mAb YL1/2 (Harlan Sera-Lab, Loughborough, England), anti-Nucleoporin p62 mAb (Transduction Laboratories, Lexington, KY) and anti-mitotic proteins mAb MPM-2 (DAKO, Carpinteria, CA) were purchased from the indicated suppliers. The polyclonal antibodies (pAb) to the HA and Myc epitope tag were purchased from MBL (Nagoya, Japan). The KRMP1 polyclonal antiserum C1163 was produced by immunizing rabbits with a synthetic peptide NH 2 -GCSKENVSQPKRAKRKLYT-COOH (the bold letters correspond to the residues 1726 to 1742 of the KRMP1 protein), coupled to keyhole limpet haemocyanin.
Molecular cloning of KRMP1-
The full-length cDNA of KRMP1 was cloned with immunoscreening and rapid amplification of cDNA ends (RACE) system (Life Technologies, Gaithersburg, MD). The UNI-ZAP HeLa cDNA expression library (Stratagene, La Jolla, CA) was immunoscreened with serum No.114 (from a scleroderma patient K.S.) as previously described (16) . Starting from more than 300,000 plaques in the 1st screening, 20 positive clones were obtained and excised into pBlueScriptII SK(-) in vivo. Overlapping two clones (No. 14 and 17 in Fig. 1A) were the pieces of a novel KRP. In this reading frame, there was a stop codon at the position -7 (nucleotides -21) upstream of a putative first codon within the clone No.14. This seems to be odd since the bacterial translation of the following sequence might not occur then, but the accuracy of the sequence is supported by some expressed sequence tag (EST) database entries in GenBank. In the 3' sequence, two clones extended to the same position without any stop codons. To obtain a carboxy-terminal stretch, 3'-RACE was performed utilizing the following primers: KP+1 corresponding to nucleotides 1181 to 1201 (5'-GTGAAAGGTTAAGAGAGACTG -3'), KP+3 nucleotides 1480 to 1499 µM ATP and purified GST-fusion proteins, and placed on ice for intervals of reaction.
Immunoprecipitations and immunoblotting-
Sodium phosphate buffer was used as P i standard sample. The reaction was incubated at 37°C for the indicated times and quenched by adding PCA solution to 0.3 M concentration. Sequence comparison of the kinesin-related motor domain indicated that KRMP1 is closely related to RB6K (12, 19, 20) , Cricetulus griseus CHO1 and Homo sapiens MKLP-1 (13, 21, 22) , Drosophila melanogaster PAV-KLP (14) and Caenorhabditis elegans ZEN-4 (15), which are thought to arise a MKLP1 subfamily ( Fig. 2A and B) . The nucleotide-binding consensus motifs, SGKT (N1 or P-loop), SSRSHS (N2) and LAGSE (N3)
RT-PCR-
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were all conserved in KRMP1. The similarity against MKLP-1 subfamily members was outstanding around these consensus motifs (27 to 41% identity within the first 500 amino acid sequence of KRMP1), while the Cterminal half remainder sequences diverged further.
To examine whether the motor domain of KRMP1 possesses intrinsic ATPase activity, we generated the corresponding sequence (residues 1 to 503; head) as GST-fusion protein and measured its ATPase activity. The wild-type GST-head hydrolyzed ATP in a time-dependent manner, whereas the mutant carrying substitution of the Lys-158 in the consensus P-loop with Arg (K158R) effectively inhibited the activity (Fig.   2C ). Furthermore, ATP hydrolysis rate was dose-dependent and the wildtype GST-head domain incubated at 4°C exhibited apparently no ATP hydrolysis (data not shown). Thus, it was confirmed that amino-terminal kinesin-related sequence of KRMP1 is an innate ATPase.
Coiled-coil formation within the central stalk domain of KRMP1-
Many KRPs have a central α-helical stalk domain through which coiledcoil oligomerization is achieved (23) . Secondary structure prediction (24) indicated that the central region of KRMP1 is likely to form an α-helical coiled-coil (Fig. 3A) . KRMP1 (1780 amino acids) expands almost twice in length as the other members of MKLP-1 subfamily (~1000 amino acids), because KRMP1 has the extraordinarily long stalk domain (~1000 amino acids, see Fig. 3A ). The role of this stalk domain on self-oligomerization was examined by co-immunoprecipitation analysis. Myc-tagged full-length KRMP1 (Myc-full) and HA-tagged full-length KRMP1 (HA-full) were coexpressed in COS-7 cells, and we found that they could associate in vivo (Fig. 3B) . To corroborate the association via the stalk domain, we employed Myc-tagged construct lacking the N-terminal motor domain (residues 504 to 1780; stalk-tail). Favorable aspect of this construct was the greater expression level than that of full-length one, although the reason for this was not uncovered. Myc-tagged stalk-tail and HA-tagged various derivatives of KRMP1 were tested for their association (Fig. 3C) .
Apparently, N-terminal half of the stalk domain (stalk1) contributed to the co- immunoprecipitation (lanes a, c, d , e, h in Fig. 3C ). HA-tagged constructs containing C-terminal half of the stalk domain (stalk2) tended to form dimer migrating at about twice size than monomer band (lanes c, f, i
in Fig. 3C ), which may explain the apparent lack or weakness of co-immunoprecipitation of Myc-stalk-tail. These data show that the central 1000 amino-acid stalk domain should contribute to the in vivo formation of an α-helical coiled-coil structure.
Identification of KRMP1 as an M-phase phosphoprotein-It has
been reported that RB6K among MKLP1 subfamily reveals cell cycledependent expression pattern, which shows a low level during interphase and a maximum during M-phase (19, 20) . We therefore examined using
RT-PCR analysis whether the expression level of KRMP1 is also regulated during the cell cycle, and found that KRMP1 was rather constantly expressed throughout the cell cycle (Fig. 4A) . Search against GenBank database revealed that 566-amino acid sequence at the C-terminus was identical to MPP1, which was previously reported as an epitope sequence for anti-mitotic proteins MPM-2 monoclonal antibody after phosphorylation by M-phase kinases (25, 26) . To determine the MPM-2 reactivity of KRMP1 during cell cycle, HeLaS3 cells were synchronized at G1/S or G2/M and then cell lysates were immunoprecipitated with antiserum to KRMP1 followed by immunoblotting using MPM-2. These results showed that MPM-2 reactivity of KRMP1 was much greater at G2/M than at G1/S (Fig. 4B) , and also revealed that the protein level of KRMP1 is likely to be invariant through the cell cycle. Together, these findings raised the possibility that the function of KRMP1 in M-phase should be switched via phosphorylation. In vivo labeling experiment of exogenously expressed KRMP1 in COS-7 cells showed that KRMP1 is actually phosphorylated in vivo (Fig. 4C) . To address the phosphorylation profile of KRMP1 in M-phase, a series of non-overlapping fragments (residues 1 to 503; head, residues 504 to 1003; stalk1, residues 1004 to 1519; stalk2, and residues 1520 to 1780; tail) covering full-length sequence of KRMP1, were purified as GST-fusion proteins and incubated with [γ- 32 P] ATP and the M-phase cell extracts. In vitro kinase assays showed that the tail domain was strongly phosphorylated and the head domain was also phosphorylated, but to a lower extent (Fig. 4D) . Furthermore, to explore whether the M-phase phosphorylation activity against KRMP1 is attributed to cdc2 kinase, the proteins described above were subjected to in vitro kinase assays using the recombinant cdc2 kinase. These results showed that the tail domain was phosphorylated with cdc2 kinase, while the head domain was not (Fig. 4E) . We also found that CK2 (caseine kinase II) was responsible for the phosphorylation of the head domain (data not shown).
To substantiate the contribution of cdc2 kinase in the phosphorylation of the tail domain with the M-phase extracts, its specific inhibitor olomoucine was added to the reaction. Olomoucine inhibited the phosphorylation of the tail domain with the M-phase extracts (Fig. 4F) . These experiments indicated that cdc2 kinase contributes to the phosphorylation of the tail domain of KRMP1 in M-phase.
There were five plausible phosphorylation sites within the tail domain (Thr-1588, Thr-1604, Thr-1635, Ser-1700, and Ser-1747) that match the consensus motif for cdc2 kinase, which is depicted as Ser or Thr residues that precedes Pro (Ser/Thr-Pro motifs). To determine the site responsible for cdc2 kinase phosphorylation, 6×His-tagged wild-type tail domain and mutants carrying the substitution of Ser/Thr with Ala were subjected to in vitro kinase assay. It was clearly demonstrated that Thr-1604 residue is required for cdc2 kinase phosphorylation (Fig. 5A ). The bimC subgroup among the kinesin family has been shown to share common motif for cdc2 kinase phosphorylation referred to as bimC box (27) , which is located within C-terminal of the protein, and the phosphorylation on it affects the association with other proteins (28) . Therefore, we aligned the sequence surrounding Thr-1604 of KRMP1 with bimC box, and found that the region differs from the bimC box conserved in bimC subgroup (Fig.   5B ). These observations indicate that, although KRMP1 belongs to mitotic KRPs, the way cdc2 kinase phosphorylates on it and the function resulting from the phosphorylation are distinct from the known case in bimC subfamily.
Subcellular localization of KRMP1-
To determine the subcellular localization of KRMP1, COS-7 cells were stained with preimmune sera or antiserum to KRMP1 (Fig. 6A ). These staining showed that endogenous KRMP1 during interphase was localized to the cytoplasm and the nucleolus, and the cytoplasmic staining often revealed perinuclear focus within centrosome (Fig. 6A) . Furthermore, the staining was diminished by the competition with the antigen peptide (Fig. 6A, right localization is diffuse over entire cell body (Fig. 6C) . Furthermore, the diffuse pattern exclusive of the region for chromosome represented the colocalization with nucleoporin p62, a component of nuclear pore complex (31) (Fig. 6D) . Such a distribution is distinct from the known patterns for kinetochore or spindle-associated motors.
KRMP1 interacts with mitotic regulator Pin1 in vivo-Flow cytometry analysis revealed that overexpression of EGFP-tagged KRMP1
for 48 h in COS-7 cells resulted in elevated proportion in G2/M peak compared to the population transfected with EGFP alone (Fig. 7A) .
Resemblance between the MPM-2 epitope and the binding motif for Pin1, a peptidyl-prolyl isomerase (PPIase) required for mitotic progression (4), gave us the idea that KRMP1 interacts with Pin1. We performed a far Western analysis using recombinant proteins, and found that the tail domain of KRMP1 bound directly to Pin1 and Pin1 R68,69A carrying mutations at the C-terminal isomerase domain, while Pin1 Y23A carrying mutation at the N-terminal WW domain reduced the binding affinity ( Therefore, our results revealed that a novel protein interacting with Pin1 in vivo was identified termed KRMP1, thus providing new insights into the molecular and cellular mechanisms underlying the mitotic process.
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FOOT NOTES
The nucleotide sequence(s) reported in this paper has been submitted to the GenBank TM /EBI Data Bank with accession number(s) AB033337 and AB033338. 1 The abbreviations used are: CK2, casein kinase II; EST, expressed sequence tag; GST, glutathione S-transferase; HA, hemagglutinin; KRP, kinesin-related protein; mAb, monoclonal antibody; pAb, polyclonal antibody; PPIase, peptidyl-prolyl isomerase; RACE, rapid amplification of cDNA ends; RT-PCR, reverse transcription-polymerase chain reaction; SDS-PAGE, sodium dodecyl sulfate-polyacrylamide gel electrophoresis;. Either EGFP or EGFP-tagged full-length KRMP1 was expressed in COS-7 cells together with increasing amounts of FLAG-tagged wild-type Pin1.
After culture for 24 h, they were then analyzed with flowcytometer (lower panel) and the population of the cells in G0/G1, S and G2/M phase were calculated, and is expressed as a percentage of the total number of cells (upper panel).
